4/A
Changes in Ownership
IMMUCELL CORP /DE/ Filed Acc 0001437749-26-009312
Options or other derivatives
- President and CEO acquired 109,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
te Boekhorst Paul Francis Olivier · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-27 | Grant or award : show line 1 in the form Stock Options (right to buy) | +109,500 | 109,500 | D |
Loading xslF345X06/rdgdoc.xml…